As the demand for COVID vaccines decreases worldwide, Moderna is planning to release a RSV vaccine, pending U.S. approval.
Moderna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting efforts took hold and sales ...
Moderna on Friday said the Food and Drug Administration won't meet its May 12 target action date for a decision on the company's proposed vaccine for respiratory syncytial virus, or RSV, but that the ...
Novavax has signed a multibillion-dollar deal with French drugmaker Sanofi to co-commercialize the company's Covid vaccine ...
A guide to the coronavirus vaccination rollout and what you need to know about the authorized vaccines Some 63.8% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna ...
Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Moderna says its updated coronavirus ...
A new study from the CDC states that there is no data to support an association between the COVID vaccines and sudden cardiac death among previously healthy young persons The COVID-19 vaccines are ...
Did the COVID Vax Cause Health Problems? The Moderna and Pfizer COVID-19 vaccines can cause myocarditis but evidence suggests they don’t cause infertility, Guillain-Barré syndrome or Bell’s ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. A top-five shareholder in struggling Covid-19 vaccine maker Novavax is calling for an “urgent shake-up ...
WATCH: Nobel in medicine goes to scientists whose work on mRNA led to COVID vaccine Hungarian-American Katalin Karikó and American Drew Weissman were cited for contributing vaccine development ...